ES2362616T3 - Derivado de imidazotiazol y proceso para producir el mismo. - Google Patents

Derivado de imidazotiazol y proceso para producir el mismo. Download PDF

Info

Publication number
ES2362616T3
ES2362616T3 ES06711975T ES06711975T ES2362616T3 ES 2362616 T3 ES2362616 T3 ES 2362616T3 ES 06711975 T ES06711975 T ES 06711975T ES 06711975 T ES06711975 T ES 06711975T ES 2362616 T3 ES2362616 T3 ES 2362616T3
Authority
ES
Spain
Prior art keywords
formula
compound
reaction
bromoimidazo
solution
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
ES06711975T
Other languages
English (en)
Spanish (es)
Inventor
Eiki Shitara
Kunio Atsumi
Keiichi Ajito
Shinya Ikeda
Tadashi Katoh
Munenori Inoue
Mari Nakatani
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Meiji Seika Kaisha Ltd
Sagami Chemical Research Institute
Original Assignee
Meiji Seika Kaisha Ltd
Sagami Chemical Research Institute
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Meiji Seika Kaisha Ltd, Sagami Chemical Research Institute filed Critical Meiji Seika Kaisha Ltd
Application granted granted Critical
Publication of ES2362616T3 publication Critical patent/ES2362616T3/es
Anticipated expiration legal-status Critical
Active legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pyrrole Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ES06711975T 2005-01-19 2006-01-19 Derivado de imidazotiazol y proceso para producir el mismo. Active ES2362616T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2005011923 2005-01-19
JP2005-11923 2005-01-19

Publications (1)

Publication Number Publication Date
ES2362616T3 true ES2362616T3 (es) 2011-07-08

Family

ID=36692304

Family Applications (1)

Application Number Title Priority Date Filing Date
ES06711975T Active ES2362616T3 (es) 2005-01-19 2006-01-19 Derivado de imidazotiazol y proceso para producir el mismo.

Country Status (11)

Country Link
US (1) US7662841B2 (Direct)
EP (1) EP1840129B1 (Direct)
JP (1) JP4964599B2 (Direct)
KR (1) KR101344137B1 (Direct)
CN (1) CN101137661B (Direct)
AU (1) AU2006207059A1 (Direct)
CA (1) CA2595009A1 (Direct)
DE (1) DE602006020545D1 (Direct)
ES (1) ES2362616T3 (Direct)
IN (1) IN2012DN00833A (Direct)
WO (1) WO2006077919A1 (Direct)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2927207A4 (en) * 2012-11-27 2016-07-13 Kureha Corp PROCESS FOR PRODUCING CARBONYL COMPOUND

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5371080A (en) * 1990-06-22 1994-12-06 Novo Nordisk A/S Imidazoquinazoline compounds and their use
ES2146661T3 (es) * 1993-09-16 2000-08-16 Meiji Seika Co Nuevos derivados de cefem.
SI0729469T1 (en) * 1993-11-19 1998-12-31 Pharmacia & Upjohn Company IMIDAZO (1,5-a)QUINOLINES FOR TREATMENT OF ANXIETY AND SLEEP DISORDERS
JP3527003B2 (ja) * 1995-03-10 2004-05-17 明治製菓株式会社 新規イミダゾ［５，１−ｂ］チアゾール誘導体
CA2279298A1 (en) 1997-01-28 1998-07-30 Kunio Atsumi New carbapenem derivatives
WO2000006581A1 (en) 1998-07-27 2000-02-10 Meiji Seika Kaisha, Ltd. Novel carbapenem derivatives
JP2005231997A (ja) * 2000-01-24 2005-09-02 Meiji Seika Kaisha Ltd カルバペネム誘導体の製造法
EP1251134A4 (en) * 2000-01-26 2003-01-29 Meiji Seika Kaisha NEW CARBAPENEM DERIVATIVES OF THE QUATERNARY SALT TYPE
CN101255171A (zh) * 2002-12-13 2008-09-03 明治制果株式会社 2-位取代碳青霉烯衍生物的中间体及其制备方法
JP2005200412A (ja) * 2003-12-19 2005-07-28 Meiji Seika Kaisha Ltd 新規２−エチニルカルバペネム誘導体

Also Published As

Publication number Publication date
EP1840129A1 (en) 2007-10-03
AU2006207059A1 (en) 2006-07-27
JPWO2006077919A1 (ja) 2008-06-19
US7662841B2 (en) 2010-02-16
KR101344137B1 (ko) 2013-12-20
CN101137661A (zh) 2008-03-05
CN101137661B (zh) 2011-06-15
EP1840129A4 (en) 2008-10-15
CA2595009A1 (en) 2006-07-27
JP4964599B2 (ja) 2012-07-04
DE602006020545D1 (de) 2011-04-21
EP1840129B1 (en) 2011-03-09
WO2006077919A1 (ja) 2006-07-27
US20080114164A1 (en) 2008-05-15
KR20070113205A (ko) 2007-11-28
IN2012DN00833A (Direct) 2015-06-26

Similar Documents

Publication Publication Date Title
EP1767538B1 (en) Process for producing 1-oxacephalosporin-7alpha-methoxy-3-chloromethyl derivative
CA2954268C (en) Process for the preparation of 3-hydroxypicolinic acids
US7563901B2 (en) Intermediates of 2-substituted carbapenem derivatives and process for production thereof
ES2362616T3 (es) Derivado de imidazotiazol y proceso para producir el mismo.
AU2002223929B2 (en) Process and ester derivatives useful for preparation of cephalosporins
JP3195371B2 (ja) セフエム誘導体の製造法
KR100439491B1 (ko) 3-술포닐옥시-3-세펨 화합물의 제조방법
KR20230084531A (ko) 5-(1-시아노사이클로프로필)-피리딘-2-카르복실산 에스테르 아미드 및 니트릴을 제조하기 위한 프로세스
CA2888543A1 (en) Processes for production of intermediates for 2-alkyl cephem compounds
ES2283781T3 (es) Procedimiento para producir un compuesto de 1,2,3-triazol.
US6150519A (en) Process for preparing β-lactam derivatives
KR100899325B1 (ko) 1-옥사세팔로스포린-7α-메톡시-3-클로로메틸 유도체의제조 방법
ES2303874T3 (es) Procedimiento de preparacion de una composicion halogena.
JP2859630B2 (ja) チアジアゾリル酢酸誘導体の製造方法およびその中間体
US5405955A (en) Method for producing azetidinone and cephalosporin derivatives
US5986091A (en) Process for preparation of β-lactam compounds
KR100309703B1 (ko) 이중고리 티올 유도체, 이를 치환기로 갖는 1-β-메틸-카바페넴 유도체, 및 그들의 제조방법
KR100228189B1 (ko) 씨-3 위치가 치환된 세펨 유도체의 제조방법 ii
JP2017160154A (ja) 新規なピロロベンゾチアジン化合物とその製造方法
JPH11209371A (ja) ベンゾ〔ｂ〕チオフェン−２，３−ジオン誘導体およびその製造方法
JPH08245634A (ja) セフェム化合物及びその製造法